Send to a Friend Font Size: Increase Decrease

ZLAB and AMGN Related Headlines

Apr 1, 2026 07:30AM Zai Lab partners with Amgen for combination cancer therapy trial
Apr 1, 2026 07:30AM Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy

ZLAB and AMGN Related Press Releases

Apr 1, 2026 07:30AM Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy

ZLAB and AMGN Related SEC Filings